Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
2
pubmed:dateCreated
2002-6-3
pubmed:abstractText
Supplementation of PBPC autografts with ex vivo expanded PBMC may significantly reduce or eliminate the period of neutropenia associated with high-dose chemotherapy.
pubmed:grant
pubmed:commentsCorrections
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
http://linkedlifedata.com/resource/pubmed/chemical/Cytokines, http://linkedlifedata.com/resource/pubmed/chemical/Glycoproteins, http://linkedlifedata.com/resource/pubmed/chemical/Granulocyte Colony-Stimulating..., http://linkedlifedata.com/resource/pubmed/chemical/Growth Substances, http://linkedlifedata.com/resource/pubmed/chemical/Interleukin-3, http://linkedlifedata.com/resource/pubmed/chemical/Peptide Fragments, http://linkedlifedata.com/resource/pubmed/chemical/Peptides, http://linkedlifedata.com/resource/pubmed/chemical/Receptors, Interleukin-3, http://linkedlifedata.com/resource/pubmed/chemical/Recombinant Fusion Proteins, http://linkedlifedata.com/resource/pubmed/chemical/Recombinant Proteins, http://linkedlifedata.com/resource/pubmed/chemical/Thrombopoietin, http://linkedlifedata.com/resource/pubmed/chemical/daniplestim, http://linkedlifedata.com/resource/pubmed/chemical/leridistim, http://linkedlifedata.com/resource/pubmed/chemical/megapoietin protein, Ovis aries
pubmed:status
MEDLINE
pubmed:issn
1465-3249
pubmed:author
pubmed:issnType
Print
pubmed:volume
2
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
85-94
pubmed:dateRevised
2011-11-17
pubmed:meshHeading
pubmed-meshheading:12042045-Cell Culture Techniques, pubmed-meshheading:12042045-Cell Differentiation, pubmed-meshheading:12042045-Cell Division, pubmed-meshheading:12042045-Cell Lineage, pubmed-meshheading:12042045-Cytokines, pubmed-meshheading:12042045-Glycoproteins, pubmed-meshheading:12042045-Granulocyte Colony-Stimulating Factor, pubmed-meshheading:12042045-Granulocytes, pubmed-meshheading:12042045-Growth Substances, pubmed-meshheading:12042045-Humans, pubmed-meshheading:12042045-Immunophenotyping, pubmed-meshheading:12042045-Interleukin-3, pubmed-meshheading:12042045-Leukocyte Count, pubmed-meshheading:12042045-Peptide Fragments, pubmed-meshheading:12042045-Peptides, pubmed-meshheading:12042045-Receptors, Interleukin-3, pubmed-meshheading:12042045-Recombinant Fusion Proteins, pubmed-meshheading:12042045-Recombinant Proteins, pubmed-meshheading:12042045-Stem Cells, pubmed-meshheading:12042045-Thrombopoietin
pubmed:year
2000
pubmed:articleTitle
Clinical-scale production of granulocyte progenitor and post-progenitor cells using daniplestim, leridistim, Progenipoietin, Promegapoietin and autologous plasma.
pubmed:affiliation
Department of Chemical Engineering, Northwestern University, Evanston and Chicago, IL, USA.
pubmed:publicationType
Journal Article, Comparative Study, Research Support, U.S. Gov't, P.H.S., Research Support, U.S. Gov't, Non-P.H.S., Research Support, Non-U.S. Gov't